Editorial
NSCLC – immunogenic after all?
Journal of Thoracic Disease
2011;
3
(2)
:79-81
.
(01 June 2011)
Primary endpoints in cancer trials
Journal of Thoracic Disease
2011;
3
(2)
:82-83
.
(01 June 2011)
Thoracic malignant solitary fibrous tumors: Prognostic factors and long-term survival
Journal of Thoracic Disease
2011;
3
(2)
:84-85
.
(01 June 2011)
Solitary fibrous tumor: A pathological enigma and clinical dilemma
Journal of Thoracic Disease
2011;
3
(2)
:86-87
.
(01 June 2011)
Original Article
Post-study therapy as a source of confounding in survival analysis of first-line studies in patients with advanced non-small-cell lung cancer
Journal of Thoracic Disease
2011;
3
(2)
:88-98
.
(01 June 2011)
Thoracic malignant solitary fibrous tumors: A population-based study of survival
Journal of Thoracic Disease
2011;
3
(2)
:99-104
.
(01 June 2011)
Review Article
Active-specific immunotherapy for non-small cell lung cancer
Journal of Thoracic Disease
2011;
3
(2)
:105-114
.
(01 June 2011)
History and current status of mini-invasive thoracic surgery
Journal of Thoracic Disease
2011;
3
(2)
:115-121
.
(01 June 2011)
Treatment of advanced non small cell lung cancer
Journal of Thoracic Disease
2011;
3
(2)
:122-133
.
(01 June 2011)
Case Report
Intracranial hemorrhage in infective endocarditis: A case report
Journal of Thoracic Disease
2011;
3
(2)
:134-137
.
(01 June 2011)
Spontaneous pneumothorax after chemotherapy for sarcoma with lung metastases: Case report and consideration of pathogenesis
Journal of Thoracic Disease
2011;
3
(2)
:138-140
.
(01 June 2011)
Case series of treatment approaches in fit nonagenarians with stage IV non-small-cell lung cancer
Journal of Thoracic Disease
2011;
3
(2)
:141-143
.
(01 June 2011)
